Mass spectrometric analysis of G
s. Native or recombinant G
s was in-gel digested and the resulting peptides analysed by MALDI-MS. Mass peaks with m/z 973.5 and 735.3 corresponded to the palmitoylated and non-palmitoylated N-terminal sequence G2CLGNSK of G
s, respectively. (A) LC chromatogram recorded for the native protein at m/z 973.5 and the recombinant protein at m/z 735.3. (B) MS/MS spectrum of m/z = 973.58 of native G
s. Relevant ions were labelled according to the accepted nomenclature and listed in Table II.
Article
- The EMBO Journal (2003) 22, 826 - 832
- doi:10.1093/emboj/cdg095
Subject Categories:
G
s is palmitoylated at the N-terminal glycine
Christiane Kleuss1 and Eberhard Krause2
- Institut für Pharmakologie, Freie Universität Berlin, Thielallee 67–73, 14195 Berlin Germany
- Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin Buch, Robert-Rössle-Strasse 10, 13125 Berlin-Buch, Germany
Correspondence to:
Christiane Kleuss, E-mail: ckleuss@zedat.fu-berlin.de
Received 21 October 2002; Accepted 23 December 2002; Revised 17 December 2002
Abstract
Covalent lipid attachments are essential co- and post-translational modifications for signalling proteins. G
s, the
-subunit of the heterotrimeric G protein that activates adenylyl cyclase, is known to be palmitoylated at the third N-terminal amino acid, a cysteine. Palmitoylation is involved in anchoring G
s to the membrane by increasing its intrinsic hydrophobicity. We identified by mass spectrometry a second, functionally even more important, covalent modification. It consists of another palmitoyl residue attached to the preceding glycine (Gly2). Palmitoylation at this position has profound consequences for levels of signal transduction. It sensitizes the cell up to 200-fold for adenylyl cyclase-stimulating agents. The inhibitory inputs mediated by G
i are downregulated to <10%. Thereby, Gly2-palmitoylation of G
s relieves cellular stimulation at the level of adenylyl cyclase whereas it renders the inhibitory modulation via G
i more difficult.
Keywords:
- adenylyl cyclase,
- Gly2-palmitoylation,
- lipid modification,
- stimulatory G protein
Introduction
Introduction
Top of pageHeterotrimeric G proteins play a pivotal role in cellular signalling. They act as molecular switches that couple diverse receptors in the plasma membrane to a variety of intracellular effectors or signal generators. Efficiency of signalling depends on individual expression levels of the signalling partners and, even more importantly, their correct localization in the signalling compartment. Not until recently did it become evident that lipid modifications are an important determinant for localizing a protein into membranes and microdomains therein (Casey, 1995; Simons and Toomre, 2000).
G proteins are richly modified by lipids, which confer functional attributes such as protein–protein interactions (Linder et al., 1990; Casey, 1994; Tu et al., 1997; Chen and Manning, 2001) and a propensity for these otherwise soluble proteins to associate with membranes. The
-subunits of members of the Gi subfamily contain amide-linked myristate, and all G
subunits (except G
t) contain palmitate in thioester linkage on one or more nearby cysteine residues.
Myristoylation occurs during protein translation, and the saturated C14-lipid is permanently attached to the G protein on the N-terminal glycine residue (Gly2) that constitutes the N-terminus after removal of the initiating methionine Met1. Myristoylated G proteins adopt substantial functional features for cell signalling (Mumby et al., 1990), with targeting G
to membranes being the most important.
In contrast, palmitoylation usually occurs at cysteine residues, is a dynamic protein modification (Cys-palmitoylation; Degtyarev et al., 1993; Mumby et al., 1994; Chen and Manning, 2000), and imparts pronounced hydrophobicity to the G
subunit (Peitzsch and McLaughlin, 1993). Differences in opinion exist concerning the general functional consequences of G protein palmitoylation: be it membrane anchorage (Wedegaertner et al., 1993; Grassie et al., 1994) and/or specific interaction with regulators (Tu et al., 1997) and/or the selective targeting into membrane subdomains (Moffett et al., 2000; Waheed and Jones, 2002). For proteins that are acylated by both fatty acids, myristoylation usually precedes palmitoylation. So far, the functional consequences of myristoylation for the proteins role in signal transduction are thought to be dominant over potential effects of Cys-palmitoylation.
G
s, discovered for its ability to stimulate production of the second messenger cAMP, is Cys3-palmitoylated like members of the G
i subfamily, but it is not myristoylated, despite the presence of an N-terminal glycine residue. However, it was consistently observed that G
s purified from sources such as mammalian liver or brain (we refer to it as 'native G
s') has a higher apparent affinity for its effector adenylyl cyclase than does the mammalian protein that had been expressed in and purified from bacteria (we refer to it as 'recombinant G
s'). Previous experiments excluded the possibility that the Cys3-attached palmitoyl moiety of G
s was responsible for this characteristic (Kleuss and Gilman, 1997). However, we reported the presence of an additional, at the time unidentified, lipophilic modification at or near the N-terminus of native G
s. Here, we determined this modification to be a second palmitoyl residue that is linked to the G protein at the extreme N-terminal glycine by an unusual amide linkage. The functional consequences of this modification for the interaction of G
s with adenylyl cyclase and plasma membrane localization are profound and are discussed in the context of signal transduction.
Results
Top of pageMass spectrometric analysis
To identify the lipophilic modification at the N-terminus of G
s, we analysed both the short and long splice variants of native G
s and the recombinant protein by peptide mass fingerprinting. Analysis of mass spectra of recombinant G
s with regard to the presence of the N-terminal sequence revealed a mass peak at m/z 735.3, corresponding to the unmodified fragment amino acid 2–8 (GCLGNSK) after trypsin digestion. The evidence for an unmodified N-terminus is based on the B- and Y-ions of the CID spectrum (retention time 12.5 min) of on-line liquid chromatography electrospray ionization tandem mass spectrometry (LC-MS/MS; Table I). Mass peaks corresponding to unmodified N-terminal sequences were not present when native, purified G
s protein was analysed by matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) or LC-MS/MS. However, we found distinct mass peaks at m/z 973.5 in MALDI spectra of Lys-C and tryptic digests of native G
s that were not present in recombinant G
s spectra (Figure 1A). We concluded that the native protein carried an additional group at the N-terminus with a mass of 238, corresponding to the size of a palmitoyl moiety.
Figure 1.
The site of modification was determined by LC-MS/MS as the N-terminal glycine (Figure 1B; Table II). Additional MS/MS experiments (data not shown) on the native G
s N-terminal peptide prepared by tryptic in-gel digestion using 4-vinylpyridine instead of iodoacetamide for cysteine alkylation, and MALDI-MS of cyanogen bromide digested native G
s confirmed these results.
To prove the chemical nature of the attached lipid, we prepared N-terminal peptides by solid-phase synthesis and chemically attached a palmitoyl group at the N-terminal glycine. As shown in mass chromatograms (m/z 973.5), the N-terminus generated by in-gel digestion of native G
s and the reference peptide, palm-GCLGNSK, exhibited identical masses and retention times in LC analysis (Figure 2). These data corroborated that the hitherto unknown modification is a palmitoyl residue that is attached to the N-terminal glycine of G
s via a covalent amide bond.
Figure 2.
LC/MS analysis. Mass chromatogram (m/z 973.5) of the peptide mixture generated by in-gel digestion of native G
s with Lys-C (A) and of the peptide palm-GCLGNSK prepared by solid-phase peptide synthesis (B). Samples were separated by HPLC and detected on-line by electrospray mass spectrometry. Indicated are signal intensities in arbitrary units (u).
In vitro palmitoylation
In a previous study, we showed that the lipophilic modification present on native G
s (i.e. the Gly2-attached palmitoyl group) increased the apparent affinity of G
s for adenylyl cyclase and the G
complex (Kleuss and Gilman, 1997). Analogously, myristoylation at Gly2 enabled high affinity interactions of G
i with the effector adenylyl cyclase (Taussig et al., 1993) and the G
complex (Linder et al., 1991). Therefore, we speculated that other features may be shared by G
i and G
s, which are caused by the individual amide-linked acyl modification. Palmitoylation of G
i and G
o occurs spontaneously when the purified protein is incubated with palmitoyl–coenzyme A (Duncan and Gilman, 1996). These authors and others (Mollner et al., 1998) also showed that autopalmitoylation of G
specifically occurred at Cys3. Incorporation of palmitate into G
i is facilitated by the presence of amide-linked myristate at Gly2. Indeed, Gly2-palmitoylation of G
s enhanced the spontaneous incorporation of radioactivity from tritiated palmitoyl–coenzyme A into the protein (Figure 3). This was corroborated by the in vitro palmitoylation of a synthetic peptide representing the seven N-terminal amino acids of G
s under similar reaction conditions. The reaction was more efficient using a peptide that was already palmitoylated at Gly2 (Figure 4, lane P versus O).
Figure 3.
Autopalmitoylation of G
s at Cys3. G
s (2.5
M) purified from recombinant bacteria (open circle) or native source (filled triangle for G
s-short, filled diamond for G
s-long) were incubated with 25
M [9,10–3H]palmitoyl–coenzyme A (20 000 c.p.m./pmol) for the indicated times at 20°C. (A) Shown are 3H-images of reaction products after electrophoretic separation and transfer onto nitrocellulose membranes (upper panel), and immunostains with G
s-specific antiserum C-18 (lower panel). (B) Relative 3H-incorporation into each protein was calculated from band intensities of the 3H-imaging normalized to the intensity of the corresponding immunostain. Recombinant G
s was palmitoylated with a stoichiometry of
0.03 as determined by the filter binding assay described previously (Duncan and Gilman, 1996), implying >40% of native G
s being palmitoylated after the 2 h incubation.
Figure 4.
Autopalmitoylation of peptides at Cys. Synthetic peptides representing the N-terminus of G
s (P, M, O: GCLGNSK) or G
i (I: GCTLSAEDK) were chemically modified at the N-terminal glycine by palmitate (P), myristate (M and I) or nothing (O). Peptides were subjected to autopalmitoylation and separated by thin-layer chromatography. Radioactivity was detected by fluorography. Shown is the fluorogram of a representative developed TLC plate. Arrows indicate the position of the bi-acylated N-terminal peptide of G
s (lipid-s), bi-acylated N-terminal peptide of G
i (lipid-i1), and the substrate palmitoyl–coenzyme A near to the origin. X denotes a non-identified spot that is already present in the substrate palmitoyl–coenzyme A and is located just above the preadsorbent/silica gel interface of the plate.
Stimulation of adenylyl cyclase
Native, Gly2-palmitoylated G
s activated membrane-bound type I adenylyl cyclase with
60-fold higher apparent affinity than recombinant, unmodified G
s (Figure 5, top). Similar observations were made on adenylyl cyclase type V, a mixture of several adenylyl cyclase subtypes (mainly type V and VI) or a bisected adenylyl cyclase (M1C1 + M2C2; Graziano et al., 1989; Kleuss and Gilman, 1997). According to the subtype of adenylyl cyclase used, the apparent Kd value of native G
s was 0.1–0.3 nM, whereas recombinant G
s stimulated the same adenylyl cyclases with an apparent Kd of 10–50 nM. For adenylyl cyclase type V, this resulted in an
200-fold higher affinity stimulation by Gly2-palmitoylated G
s compared with recombinant G
s. The effect of Gly2-palmitoylation on G
s was not apparent with a soluble adenylyl cyclase (Figure 5, bottom). [Please note that 'soluble adenylyl cyclase' is an artificial construct of mammalian particulate adenylyl cyclase engineered to be soluble according to Tang et al. (Tang and Gilman, 1995) and does not refer to the mammalian soluble adenylyl cyclase expressed in testes.] In contrast, recombinant G
s developed similar apparent affinities for all forms of adenylyl cyclase under the experimental conditions applied. There existed two major differences between the adenylyl cyclases used: (i) soluble adenylyl cyclase is devoid of amino acids representing the two hydrophobic clusters of mammalian particulate adenylyl cyclase; and (ii) soluble adenylyl cyclase is not localized at the membrane where particulate adenylyl cyclase naturally resides. To test whether the membrane localization of adenylyl cyclase was necessary for native G
s to stimulate with high affinity, we anchored the soluble, catalytic parts of adenylyl cyclase into the plasma membrane by fusion to the heterologeous transmembrane span of the CD8-receptor (see Figure 5, centre). Concomitant expression of fusion constructs of both catalytic parts of adenylyl cyclase, CD8-C1 and CD8-C2, resulted in a particulate cAMP-generating enzyme. Gly2-palmitoylated G
s stimulated this membrane-anchored adenylyl cyclase construct more efficiently than non-modified G
s, indicating that high affinity stimulation was principally mediated by the membrane localization of the effector, not by topological or sequence-specific features of full-length adenylyl cyclase.
Figure 5.
Stimulation of adenylyl cyclase constructs by G
s. Membranes (2
g protein) containing particulate adenylyl cyclase or soluble protein (20
g, partially purified by Ni2+–NTA agarose) were used. Increasing amounts of GTP
S-activated G
s purified from bovine brain (native; closed circle) or bacterially expressed protein (recombinant; open circles) were added. Shown are adenylyl cyclase activities of full-length particulate adenylyl cyclase type I (top), soluble adenylyl cyclase halves anchored to the plasma membrane by fusion to the transmembrane span of the CD8-receptor (CD8-C1 + CD8-C2; center), and soluble adenylyl cyclase (bottom). The cartoons depict the putative topology of expressed adenylyl cyclase constructs; the CD8-span of adenylyl cyclase fusion construct is coloured grey. Values are representative of one experiment out of three similar assays performed in duplicates, SD is indicated.
Inhibition of adenylyl cyclase
The increased affinity of Gly2-palmitoylated G
s for particulate adenylyl cyclase not only enhanced the ability of G
s to stimulate adenylyl cyclase, but also considerably attenuated the efficiency of G
i to inhibit the same effector. G
i reconstitution showed high affinity interaction and regulation of adenylyl cyclase type V and VI and, to a lesser extent, type I, depending on the status of G
i lipid modification. Myristoylated G
i inhibited adenylyl cyclase with an IC50 of
0.1
M (Taussig et al., 1993), whereas non-myristoylated G
i was inactive (Linder et al., 1990). The presence of the palmitoyl modification at Cys3 in addition to the Gly2-myristoylation did not affect these regulatory features of G
i (C.Kleuss, unpublished results). The inhibitory action of myristoylated G
i is only evident if adenylyl cyclase had been pre-stimulated, either by forskolin or naturally by G
s. If recombinant G
s was used for pre-stimulation, myristoylated G
i efficiently inhibited adenylyl cyclase type V (Figure 6). If adenylyl cyclase had been pre-stimulated by native G
s, myristoylated G
i was a less-efficient inhibitor of cAMP-generating activity with an IC50 of 1
M.
Figure 6.
Inhibition of adenylyl cyclase. Recombinant adenylyl cyclase type V in insect cell membranes (10
g protein) was reconstituted with GTP
S-activated myristoylated G
i to give the indicated final concentrations in the presence of 0.1 nM GTP
S-bound native G
s (filled squares) or 20 nM GTP
S-bound recombinant G
s (open squares). Please note, we determined the inhibitory action of myristoylated G
i at comparable levels of adenylyl cyclase pre-stimulated activity by using only 1/200 the amount of Gly2-palmitoylated than non-palmitoylated G
s. Pre-stimulated adenylyl cyclase activity in the absence of G
i (100% activity) was 3.8 nmol/min/mg protein for recombinant G
s and 4.2 nmol/min/mg protein for native G
s. Values are representative of one experiment out of three similar assays, mean SEM of duplicates was below 1%.
Discussion
Top of pageNative G
s is modified at the N-terminal glycine (Gly2 after removal of the starter methionine) by a palmitoyl residue, as shown by mass spectrometric analysis. The Gly2-palmitoylation was determined on both native G
s splice variants, and is presumed to be a permanent modification due to the chemical stability of the amide-linkage as evident by its stability during the lengthy purification procedure of native G
s.
Gly2-palmitoylation and Cys3-palmitoylation
Our mass spectrometric data revealed only one palmitoyl group at the N-terminus of G
s (at Gly2). Cys3-palmitoylation is reversible under mild experimental conditions, while Gly2-palmitoylation is permanent and stable. Therefore, native G
s most probably was already devoid of Cys3-attached palmitate in the end of our purification procedure. Nevertheless, prior to mass spectrometric analysis, we modified all cysteines present in the protein to remove disulfide bonds so that any residual S-palmitoyl modification (at Cys3) would also have been removed from G
s. For the biochemical characterization, the Cys3-palmitoylation status of G
s was irrelevant, as previously described (Kleuss and Gilman, 1997). Under cellular conditions, G
s most probably is temporarily palmitoylated on both residues, Gly2 and Cys3. The two neighbouring palmitoyl groups in G
s are not equivalent, in contrast to other dually palmitoylated signalling proteins known to date. The newly described palmitoyl group on Gly2 is attached via an amide linkage, while the palmitoyl group at Cys3 is attached via a thioester bond (Linder et al., 1993). So far, palmitoylation via an N-terminal glycine was unknown to occur on heterotrimeric G proteins. Furthermore, palmitoylation via an amide bond (N-terminal cysteine or internal lysine) seems to be rare. N-palmitoylation has been reported for the vertebrate Sonic hedgehog protein (Pepinsky et al., 1998) and for the adenylyl cyclase of Bordetella pertussis (Hackett et al., 1994). Palmitoylation of Sonic hedgehog, which occurs via an amide bond at the N-terminal cysteine, is required for its embryonic patterning activities. The adenylyl cyclase of B.pertussis, consisting of 1706 amino acids, is internally palmitoylated at Lys983. Toxicity of this adenylyl cyclase (i.e. the cell-invasive activity) is directly dependent on the palmitoylation at Lys983. This exclusive group of molecules that gain their signalling abilities by N-palmitoylation is now extended to G
s. The distinct chemical nature of the two acyl anchors of G
s implies different mechanisms of palmitoylation and potentially indicates divergent functional consequences for the protein. In particular, the functional consequences of Gly2-palmitoylation of G
s resemble those of myristoylation of G
i (at Gly2; both proteins can be additionally acylated by palmitate at their Cys3) rather than the doubly palmitoylated G
q (palmitoylation at Cys9 and Cys10).
Palmitoyl transfer reaction
The existence of a palmitoylated Gly2 in G
s adds a new dimension to the discussion about palmitoyltransferases. Although palmitoylation was first described over thirty years ago, the molecular mechanism of palmitate addition has been a matter of controversy. An activity capable of palmitoylating G
has been detected in mammalian plasma membranes (Dunphy et al., 1996). Unfortunately, the proteins responsible for this activity defied purification till now (Berthiaume and Resh, 1995; Dunphy et al., 2001). On the other hand, myristoylated G
subunits can be palmitoylated at the same sites that become palmitoylated in vivo in the absence of a specific acyltransferase using palmitoyl–coenzyme A as the acyl donor (Duncan and Gilman, 1996), raising the question of the requirement for an exogenous enzyme. Skinny hedgehog/sightless was identified as a palmitoyltransferase for Drosophila hedgehog (Chamoun et al., 2001). Hedgehog is palmitoylated through an atypical cysteine amide linkage at the N-terminus. However, it seems unlikely that skinny hedgehog can palmitoylate G
s at Gly2, as both proteins are not homologous in their N-termini and, moreover, the target amino acid in hedgehog is a cysteine residue.
Recently, a palmitoyltransferase that acylates through a conventional thioester linkage, was identified in yeast (Lobo et al., 2002). Erf2p/Erf4p can directly mediate palmitate transfer to yeast Ras using palmitoyl–coenzyme A as a donor. It remains to be shown that mammalian homologues of Erf2p/Erf4p act as palmitoyltransferases on mammalian Ras and/or G
proteins (Cys3). Nevertheless, a putative Erf2p/Erf4p homologue is most likely not the catalyst for the Gly2 palmitoylation of G
s. However, it is conceivable that a transacylation reaction from Cys3 onto Gly2 takes place. A similar reaction mechanism was already described for Sonic hedgehog N-terminal palmitoylation where palmitate is transferred from the thioester-bonded cysteine onto the amino group of the same cysteine after removal of the N-terminal signal peptide. The palmitate-transacylation reaction is compatible with preliminary data on Cys3 mutants that prevent Gly2-palmitoylation (data not shown).
Gly2-palmitoylation impacts Cys3-palmitoylation of G
s
In vivo, the exchange of palmitate at Cys3 in G
s and G
i is enhanced upon stimulation of the coupling receptor through the combined processes of depalmitoylation and palmitoylation (Mumby et al., 1994; Chen and Manning, 2000). Wang et al. (1999) described that, beyond membrane anchorage, myristoylation of G
o (at Gly2) is important for the subsequent Cys3-palmitoylation. Similarly, for G
s we show here that Gly2-palmitoylation facilitated the incorporation of the additional, reversibly attached palmitoyl residue at Cys3 thereby enabling G
s to switch between a lower (Gly2-palmitoylated G
s) and higher hydrophobicity (Gly2- plus Cys3-palmitoylated protein). We observed increased Cys3-autopalmitoylation upon Gly2-palmitoylation in both, the short and long, splice variants of native G
s. Autoacylation was also enhanced in short synthetic peptides used in model reactions to represent the N-termini of G
s and G
i. Apparently, the exact chemical nature of the lipid attached to Gly2 was less important. A synthetic peptide representing the N-terminus of G
s modified with myristate at the N-terminal glycine residue, i.e. a non-physiological modification for G
s, incorporated radioactivity as well as the palmitoylated peptide (see Figure 4, lane M). The underlying mechanism may be the preferred distribution of native G
s or the corresponding Gly-acylated peptide into detergent micelles that harbour the substrate, palmitoyl–coenzyme A, thereby increasing the local concentration of the reaction partners and the mass-driven reaction.
Gly2-palmitoylation of G
s impacts regulation of adenylyl cyclase
A similar distribution phenomenon may contribute to the mechanism that renders Gly2-palmitoylated G
s more efficient to stimulate particulate adenylyl cyclase: Gly2-palmitoylation directs G
s into the plasma membrane to locally increase the protein concentration required for an efficient stimulatory coupling to the membrane-bound adenylyl cyclase. It is still unknown whether Gly2-palmitoylation of G
s also enables a lipid–protein interaction with specific transmembrane regions of adenylyl cyclase. Such a lipid–protein contact would require a second binding site of G
s on adenylyl cyclase, i.e. an additional one to the protein–protein interaction domains shown in the crystal structure of adenylyl cyclase complexed with recombinant G
s (Sunahara et al., 1997). This possibility seems, however, to be somewhat remote because the mere attachment of the adenylyl cyclase catalyst via the CD8 anchor already was sufficient to observe the functional consequences of Gly2-palmitoylation at G
s on adenylyl cyclase activity. However, we are aware of the different shaped concentration–activity curves of full-length adenylyl cyclase and the membrane-anchored constructs indicating some, although not a major, function of transmembrane spans of adenylyl cyclase in G
s activation. We also observed subtle differences of native G
s affinity for particulate adenylyl cyclase chimeras consisting of transmembrane spans derived from different adenylyl cyclase subtypes (mixed from adenylyl cyclase type I and II; data not shown). Taken together, we cannot exclude a specific lipid contact with adenylyl cyclase transmembrane domains formed by both clusters in an isoform-specific manner.
A lipophilic binding site in adenylyl cyclase transmembrane domains could also explain the different efficiencies of myristoylated G
i to inhibit adenylyl cyclase type V according to the type of G
s protein used for pre-stimulation. From three-dimensional structure and mutational analysis, it is evident that G
s and G
i interact with diagonally separated sites of distinct cytoplasmic halves of adenylyl cyclase. Therefore, the likely mechanism exerted by both G
subunits is an allosteric adenylyl cyclase regulation rather than a direct competition at those effector domains (Taussig et al., 1993). Surprisingly, myristoylated G
i was a less efficient inhibitor of adenylyl cyclase if pre-stimulation was performed with 0.1 nM Gly2-palmitoylated G
s compared with 20 nM non-palmitoylated G
s. Therefore, an additional contact between the transmembrane domains of adenylyl cyclase and the acyl modification of one or the other G
subunit seemed conceivable. In such a scenario, the different acyl chains attached to G
might compete for a similar lipophilic binding site in adenylyl cyclase transmembrane domains, thereby superimposing the allosteric regulation mediated by adenylyl cyclase cytosolic domains and the membrane-delimited competition.
Irrespectively of the underlying mechanism, Gly2-palmitoylation of G
s has profound functional consequences for Gs-mediated signal transduction at the level of adenylyl cyclase regulation. Gly2-palmitoylated G
s (in contrast to non-palmitoylated or Cys3-palmitoylated G
s) renders the cell more receptive for stimulatory inputs and less sensitive for inhibitory stimuli that are transmitted by G protein
-subunits. This process adds a new layer of regulatory possibilities to this exceedingly important signal transduction system.
Materials and methods
Top of pageIn-gel digestion
Native and recombinant G
s were subjected to polyacrylamide gel electrophoresis. After visualization and destaining, G
s spots were excised, washed with 50% (v/v) acetonitrile in 25 mM ammonium bicarbonate, shrunk by dehydration in acetonitrile and dried in a vacuum centrifuge. Disulfide bonds were reduced by incubation in 30
l of 10 mM DTT/100 mM ammonium bicarbonate in water (45 min at 55°C). Alkylation was performed by replacing the DTT solution with 55 mM iodoacetamide or 90 mM 4-vinylpyridine in 25 mM ammonium bicarbonate. After 20 min incubation at 25°C in the dark, the gel pieces were washed with 50–100
l of 50% (v/v) acetonitrile in 25 mM ammonium bicarbonate, shrunk by dehydration in acetonitrile and dried in a vacuum centrifuge. The gel pieces were re-swollen in 10
l of 5 mM ammonium bicarbonate, containing 500 ng endoproteinase Lys-C or trypsin (sequencing grade; Roche Diagnostics, Mannheim, Germany). After 15 min, 5
l of 5 mM ammonium bicarbonate was added to keep the gel pieces wet during cleavage (37°C, overnight). For extraction, 15
l of 0.5% (v/v) trifluoroacetic acid (TFA) in acetonitrile was added, followed by sonication for 5 min.
MALDI-MS
Measurements were performed on a Voyager-DE STR BioSpectrometry Workstation MALDI-TOF mass spectrometer (Perseptive Biosystems, Inc., Framingham, MA). Briefly, samples were prepared with
-cyano-4-hydroxycinnamic acid matrix and measured in the reflection mode at an acceleration voltage of 20 kV and a delay of 200 ns. Peptides from the tryptic and Lys-C digested proteins covered 71% (281 out of 394 amino acids) of the protein (SwissProt accession No. P04896).
LC-MS/MS
For on-line LC-MS measurements, 10
l of the peptide mixture from in-gel digestion was dried under vacuum, redissolved in 5
l of 20% (v/v) acetonitrile/0.1% (v/v) TFA in water, and subjected to reversed-phase HPLC separation on a C18 column (Vydac 218TP5115, 150
1 mm i.d., 5
m, Promochem, Wesel, Germany). Elution was performed at a flow rate of 30
l/min generated by a model 140B Applied Biosystems solvent delivery system. Mobile phase A was 0.06 % TFA in water and B was 0.05% TFA in acetonitrile–water (8:2, v/v). Runs were performed using a linear gradient of 25–95% B and 50–95% B in 40 min for recombinant and native G
s, respectively. Mass spectrometry was performed on-line on a triple quadrupole instrument (TSQ 700, Finnigan MAT, Bremen, Germany) equipped with the standard electrospray ion source operating in the positive mode with a capillary temperature of 200°C and a voltage of 4.5 kV. Nitrogen was introduced as sheath gas at a pressure of 3.4 bar and auxiliary gas (flow 960 ml/min). A sheath liquid of isopropanol–propionic acid (25:75, v/v) was applied at a flow rate of 4
l/min. Total ion chromatograms and mass spectra (scan range 300–1600 m/z) were acquired. Fragment ion spectra were generated by collision-induced dissociation (CID) using argon as collision gas (3–4 mTorr) and collision energies ranging from 20 to 40 eV.
Peptide synthesis
Synthetic peptides representing the N-terminus of G
s (GCLGNSK) were synthesized by solid-phase methods using Fmoc (N
-9-fluorenylmethoxycarbonyl) chemistry in the continuous flow mode (Beyermann et al., 1996). The N-terminal glycine was acylated with palmitic acid or myristic acid using the amino acid coupling chemistry. After cleavage from the resin support, cysteine alkylation was performed by 55 mM iodoacetamide in 100 mM ammonium bicarbonate. Peptides were purified by preparative high-performance liquid chromatography to give final products of >95% purity.
Autopalmitoylation
Autopalmitoylation was performed according to Duncan and Gilman (1996). Recombinant G
s protein was used as the C-terminal H6-tagged protein as described previously (Kleuss and Gilman, 1997). Native G
s was purified from bovine brain. Due to the lengthy purification procedure in the presence of 1–3 mM DTT, the native Gly2-palmitoylated G
s used throughout this study was not supposed to contain Cys3-attached palmitate. Briefly, 2.5
M G
s was incubated with 25
M [9,10–3H]palmitoyl–coenzyme A (20 000 c.p.m./pmol) for 90 min if not otherwise indicated. Peptides were solubilized in DMSO and autopalmitoylated under similar conditions [final concentration 1% (w/v) DMSO]. Proteins were separated by polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Dried membranes were exposed to 3H-imaging screens before proteins were immunostained with G
s-specific antiserum C-18. Autoacylated peptides were applied to thin layer chromatography on discontinuous silica plates (Whatman LK6D Silica Gel, 60 Å) and developed in n-butanol: pyridine:acetic acid:water (60:30:5:15) for 3 h. Radioactivity was detected by fluorography.
Adenylyl cyclase
Adenylyl cyclases and mutants thereof were expressed in Sf9 cells using recombinant baculoviruses (Weitmann et al., 2001). Viruses encoding adenylyl cyclase type I and V were kindly provided by the laboratory of A.G.Gilman. Generation of viruses encoding bisected adenylyl cyclases type I and II was described previously (Weitmann et al., 1999), as well as generation of viruses encoding the soluble His6-tagged adenylyl cyclase (Weitmann et al., 2001). Fusion constructs of CD8 (coding for amino acids 1–217 of the CD8 receptor; GI number 22902133) with sequences coding for domain C1 of adenylyl cyclase type I and domain C2 of adenylyl cyclase type II, were generated by PCR using SalI recognition site as junction. The extracellular portion of the CD8 receptor was proposed to dimerize. Consequently, dimerization of the membrane anchored catalytic parts of adenylyl cyclase was alleviated. All adenylyl cyclases were expressed for 48–55 h in insect cells; cells were harvested and plasma membranes or cytosol were prepared by nitrogen cavitation. Membranes were washed and flash frozen as well as cytosolic fractions. Adenylyl cyclase activity was measured for 10 min at 30°C in the presence of 2
M forskolin and/or G
s as indicated (Kleuss and Gilman, 1997).
Miscellaneous
Immunoblotting was performed with commercially available antibodies (Santa Cruz). Labelled samples on nitrocellulose membranes or silica plates were visualized by 3H-imaging system (BAS-1500, Fuji Film) or exposure to Biomax MS films (Kodak); quantification was performed with IPLab Gel (Signal Analytics, Vienna, VA).
Acknowledgements
Top of pageWe gratefully acknowledge A.G.Gilman and members of his research group for encouragement and advice during the initiation of this project. In addition, we thank C.Belanger for advice in peptide labelling, M.Beyermann for chemical peptide synthesis and N.Würsig for excellent technical help. We appreciate the permanent and constructive support by M.E.Linder, S.M.Mumby and H.Schmidt. The work was supported by DFG (Kl 773/4; SFB 366/A14 to C.K.).
References
Top of pageBerthiaume L and Resh MD (1995) Biochemical characterization of a palmitoyl acyltransferase activity that palmitoylates myristoylated proteins. J Biol Chem, 270, 22399–22405. | Article | PubMed | ISI | ChemPort |
Beyermann M, Fechner K, Furkert J, Krause E and Bienert M (1996) A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor. J Med Chem, 39, 3324–3330. | Article | PubMed | ISI | ChemPort |
Casey PJ (1994) Lipid modifications of G proteins. Curr Opin Cell Biol, 6, 219–225. | Article | PubMed | ISI | ChemPort |
Casey PJ (1995) Protein lipidation in cell signaling. Science, 268, 221–225. | Article | PubMed | ISI | ChemPort |
Chamoun Z, Mann RK, Nellen D, von Kessler DP, Bellotto M, Beachy PA and Basler K (2001) Skinny hedgehog, an acyltransferase required for palmitoylation and activity of the hedgehog signal. Science, 293, 2080–2084. | Article | PubMed | ISI | ChemPort |
Chen CA and Manning DR (2000) Regulation of G
i palmitoylation by activation of the 5-HT1A receptor. J Biol Chem, 275, 23516–23522. | Article | PubMed | ISI | ChemPort |
Chen CA and Manning DR (2001) Regulation of G proteins by covalent modification. Oncogene, 20, 1643–1652. | Article | PubMed | ISI | ChemPort |
Degtyarev MY, Spiegel AM and Jones TL (1993) Increased palmitoylation of the Gs protein
subunit after activation by the
-adrenergic receptor or cholera toxin. J Biol Chem, 268, 23769–23772. | PubMed | ISI | ChemPort |
Duncan JA and Gilman AG (1996) Autoacylation of G protein
subunits. J Biol Chem, 271, 23594–23600. | Article | PubMed | ISI | ChemPort |
Dunphy JT, Greentree WK, Manahan CL and Linder ME (1996) G-protein palmitoyltransferase activity is enriched in plasma membranes. J Biol Chem, 271, 7154–9. | Article | PubMed | ISI | ChemPort |
Dunphy JT, Greentree WK and Linder ME (2001) Enrichment of G-protein palmitoyltransferase activity in low density membranes: in vitro reconstitution of G
i to these domains requires palmitoyltransferase activity. J Biol Chem, 276, 43300–43304. | Article | PubMed | ISI | ChemPort |
Grassie MA, McCallum JF, Guzzi F, Magee AI, Milligan G and Parenti M (1994) The palmitoylation status of the G-protein Go1
regulates its activity of interaction with the plasma membrane. Biochem J, 302, 913–920. | PubMed | ISI | ChemPort |
Graziano MP, Freissmuth M and Gilman AG (1989) Expression of Gs
in Escherichia coli. Purification and properties of two forms of the protein. J Biol Chem, 264, 409–418. | PubMed | ISI | ChemPort |
Hackett M, Guo L, Shabanowitz J, Hunt DF and Hewlett EL (1994) Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science, 266, 433–435. | PubMed | ISI | ChemPort |
Kleuss C and Gilman AG (1997) Gs
contains an unidentified covalent modification that increases its affinity for adenylyl cyclase. Proc Natl Acad Sci USA, 94, 6116–6120. | Article | PubMed | ChemPort |
Linder ME, Ewald DA, Miller RJ and Gilman AG (1990) Purification and characterization of Go
and three types of Gi
after expression in Escherichia coli. J Biol Chem, 265, 8243–8251. | PubMed | ISI | ChemPort |
Linder ME, Pang IH, Duronio RJ, Gordon JI, Sternweis PC and Gilman AG (1991) Lipid modifications of G protein subunits. Myristoylation of Go
increases its affinity for 
. J Biol Chem, 266, 4654–4659. | PubMed | ISI | ChemPort |
Linder ME, Middleton P, Hepler JR, Taussig R, Gilman AG and Mumby SM (1993) Lipid modifications of G proteins:
subunits are palmitoylated. Proc Natl Acad Sci USA, 90, 3675–3679. | PubMed | ChemPort |
Lobo S, Greentree WK, Linder ME and Deschenes RJ (2002) Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae. J Biol Chem, 277, 41268–41273. | Article | PubMed | ISI | ChemPort |
Moffett S, Brown DA and Linder ME (2000) Lipid-dependent targeting of G proteins into rafts. J Biol Chem, 275, 2191–2198. | Article | PubMed | ISI | ChemPort |
Mollner S, Ferreira P, Beck K, Pfeuffer T (1998) Nonenzymatic palmitoylation at Cys3 causes extra-activation of the
-subunit of the stimulatory GTP-binding protein Gs. Eur J Biochem 257, 236–241. | Article | PubMed | ISI | ChemPort |
Mumby SM, Heukeroth RO, Gordon JI and Gilman AG (1990) G-protein
-subunit expression, myristoylation, and membrane association in COS cells. Proc Natl Acad Sci USA, 87, 728–732. | PubMed | ChemPort |
Mumby SM, Kleuss C and Gilman AG (1994) Receptor regulation of G-protein palmitoylation. Proc Natl Acad Sci USA, 91, 2800–2804. | Article | PubMed | ChemPort |
Peitzsch RM and McLaughlin S (1993) Binding of acylated peptides and fatty acids to phospholipid vesicles: pertinence to myristoylated proteins. Biochemistry, 32, 10436–10443. | Article | PubMed | ISI | ChemPort |
Pepinsky RB (1998) Identification of a palmitic acid-modified form of human Sonic hedgehog. J Biol Chem, 273, 14037–14045. | Article | PubMed | ISI | ChemPort |
Simons K and Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol, 1, 31–39. | Article | PubMed | ISI | ChemPort |
Sunahara RK, Tesmer JJ, Gilman AG and Sprang SR (1997) Crystal structure of the adenylyl cyclase activator Gs
. Science, 278, 1943–1947. | Article | PubMed | ISI | ChemPort |
Tang WJ and Gilman AG (1995) Construction of a soluble adenylyl cyclase activated by Gs
and forskolin. Science, 268, 1769–1772. | Article | PubMed | ISI | ChemPort |
Taussig R, Iniguez-Lluhi JA and Gilman AG (1993) Inhibition of adenylyl cyclase by Gi
. Science, 261, 218–221. | PubMed | ISI | ChemPort |
Tu Y, Wang J and Ross EM (1997) Inhibition of brain Gz GAP and other RGS proteins by palmitoylation of G protein
subunits. Science, 278, 1132–1135. | Article | PubMed | ISI | ChemPort |
Waheed AA and Jones ZTL (2002) Hsp90 interactions and acylation target the G-protein G
12, but not G
13 to lipid rafts. J Biol Chem, 277, 32409–32412. | Article | PubMed | ISI | ChemPort |
Wang Y, Windh RT, Chen CA and Manning DR (1999) N-myristoylation and 
play roles beyond anchorage in the palmitoylation of the G protein
o subunit. J Biol Chem, 274, 37435–37442. | Article | PubMed | ISI | ChemPort |
Wedegaertner PB, Chu DH, Wilson PT, Levis MJ and Bourne HR (1993) Palmitoylation is required for signaling functions and membrane attachment of Gq
and Gs
. J Biol Chem, 268, 25001–25008. | PubMed | ISI | ChemPort |
Weitmann S, Würsig N, Navarro JM and Kleuss C (1999) A functional chimera of mammalian guanylyl and adenylyl cyclases. Biochemistry, 38, 3409–3413. | Article | PubMed | ISI | ChemPort |
Weitmann S, Schultz G and Kleuss C (2001) Adenylyl cyclase type II domains involved in G
stimulation. Biochemistry, 40, 10853–10858. | Article | PubMed | ISI | ChemPort |


s [M + H]+ = 735.3
